Ultrasound Guided Supraclavicular Nerve Block

Completed · Phase 3

Conditions studied: Local Anesthetic

In brief

This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and a longer duration of analgesia than an equi-dose mixture of the two local anesthetics.

Key facts

Study ID

NCT00825786

Run by

The Cleveland Clinic

People needed

103

Starts

2008-09-01

Expected to finish

2010-08-01

Last updated by the study team

2017-06-14

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing upper extremity procedures suitable for supraclavicular anesthesia, including but not limited to oHand surgery oForearm surgery oElbow surgery
• Age between 18 and 70 years

You may not qualify if…

• Contraindications to supraclavicular block
• Coagulopathy
• Infection at the needle insertion site
• Severe chronic obstructive pulmonary disease (COPD)
• Contralateral pneumothorax or diaphragmatic paralysis
• Pregnancy
• Preexisting neuropathy involving the surgical limb
• Routine opioid use
• Inability to attain adequate ultrasound images in the supraclavicular area

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.